KUWAIT CITY, Sept 18: Chairman of the Council of Nuclear Medicine Departments and Head of the Nuclear Medicine Department at the Kuwait Cancer Control Center, Dr. Abdul-Rida Abbas, confirmed that Kuwait is the first in Asia to use radioisotopes to treat prostate cancer and nerve tumors since their global adoption, reports Al-Rai daily.

This came during the regional training course on treatment using radioactive materials for patients with prostate cancer and neurohormonal tumors, which was launched yesterday, and is being held by the Kuwait Cancer Control Center in cooperation with the Atomic Energy Agency (IAEA), with the participation of 40 specialists from Arab countries in Asia, including Gulf countries, Iraq and Yemen. In addition to the participation of four international and six local experts who will give a number of lectures.

Abbas stated that prostate cancer is the most common among men, but the world is currently witnessing a remarkable development in treatment methods using radioisotopes, which have proven their effectiveness and achieved tangible positive results.

He explained that treatments in the past were limited to hormonal and chemical treatments, but in the last three years there has been international adoption of the use of radioactive isotopes in treating cases of prostate cancer and nerve tumors, “and this is what the current session is based on to discuss and expand the benefit at the local and Arab levels in Asia.”